Sara Louise Weisenbach, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Apathy | 2 | 2021 | 107 | 1.360 |
Why?
|
Depressive Disorder | 6 | 2020 | 3728 | 1.360 |
Why?
|
Depressive Disorder, Major | 20 | 2024 | 4760 | 1.300 |
Why?
|
Facial Expression | 7 | 2017 | 508 | 0.730 |
Why?
|
Cognition | 8 | 2018 | 6973 | 0.720 |
Why?
|
Depression | 8 | 2021 | 8104 | 0.700 |
Why?
|
Neuropsychological Tests | 18 | 2020 | 7029 | 0.670 |
Why?
|
Emotions | 11 | 2018 | 2735 | 0.670 |
Why?
|
Dementia, Vascular | 2 | 2014 | 122 | 0.530 |
Why?
|
Hydrocortisone | 4 | 2018 | 1815 | 0.530 |
Why?
|
Pituitary-Adrenal System | 2 | 2018 | 549 | 0.520 |
Why?
|
Verbal Learning | 3 | 2015 | 463 | 0.520 |
Why?
|
Hypothalamo-Hypophyseal System | 2 | 2018 | 698 | 0.490 |
Why?
|
Aging | 5 | 2018 | 8689 | 0.490 |
Why?
|
Bipolar Disorder | 6 | 2018 | 5089 | 0.450 |
Why?
|
Neurobiology | 1 | 2014 | 137 | 0.440 |
Why?
|
Motivation | 2 | 2021 | 2006 | 0.440 |
Why?
|
Semantics | 5 | 2018 | 601 | 0.410 |
Why?
|
Gait | 1 | 2015 | 816 | 0.340 |
Why?
|
Cerebrovascular Disorders | 1 | 2016 | 1475 | 0.340 |
Why?
|
Cognition Disorders | 6 | 2020 | 3975 | 0.300 |
Why?
|
Memory, Short-Term | 1 | 2014 | 981 | 0.290 |
Why?
|
Public Health | 1 | 2021 | 2665 | 0.290 |
Why?
|
Association Learning | 3 | 2018 | 221 | 0.280 |
Why?
|
Age of Onset | 4 | 2015 | 3302 | 0.280 |
Why?
|
Cerebral Cortex | 6 | 2018 | 5764 | 0.270 |
Why?
|
Phenotype | 1 | 2024 | 16585 | 0.260 |
Why?
|
Executive Function | 5 | 2020 | 1383 | 0.260 |
Why?
|
Brain Mapping | 10 | 2017 | 6603 | 0.260 |
Why?
|
Neurodegenerative Diseases | 1 | 2014 | 1084 | 0.250 |
Why?
|
Cues | 4 | 2018 | 874 | 0.230 |
Why?
|
Mood Disorders | 4 | 2021 | 1127 | 0.230 |
Why?
|
Amygdala | 4 | 2017 | 1353 | 0.200 |
Why?
|
Alzheimer Disease | 3 | 2021 | 8579 | 0.200 |
Why?
|
Attention | 4 | 2015 | 2391 | 0.190 |
Why?
|
Reaction Time | 2 | 2018 | 2078 | 0.180 |
Why?
|
Concept Formation | 1 | 2021 | 161 | 0.180 |
Why?
|
Memory Disorders | 3 | 2019 | 1198 | 0.170 |
Why?
|
Antidepressive Agents | 3 | 2020 | 2897 | 0.160 |
Why?
|
Aged | 20 | 2024 | 168840 | 0.160 |
Why?
|
Prefrontal Cortex | 3 | 2018 | 2218 | 0.160 |
Why?
|
Memory | 3 | 2018 | 2182 | 0.160 |
Why?
|
Brain | 10 | 2018 | 27060 | 0.160 |
Why?
|
Psychomotor Performance | 2 | 2019 | 1880 | 0.160 |
Why?
|
Humans | 44 | 2024 | 760437 | 0.160 |
Why?
|
Mental Recall | 2 | 2015 | 1213 | 0.150 |
Why?
|
Young Adult | 19 | 2019 | 59068 | 0.150 |
Why?
|
Dopamine | 3 | 2012 | 1603 | 0.150 |
Why?
|
Case-Control Studies | 8 | 2018 | 22097 | 0.150 |
Why?
|
Saliva | 2 | 2018 | 827 | 0.140 |
Why?
|
Psychotherapy | 2 | 2024 | 1646 | 0.140 |
Why?
|
Neural Pathways | 5 | 2017 | 3049 | 0.140 |
Why?
|
Quality of Life | 2 | 2017 | 13338 | 0.130 |
Why?
|
Acetylcholine | 2 | 2010 | 628 | 0.130 |
Why?
|
Sex Characteristics | 3 | 2017 | 2633 | 0.120 |
Why?
|
Social Adjustment | 1 | 2017 | 632 | 0.120 |
Why?
|
Neostriatum | 1 | 2016 | 246 | 0.120 |
Why?
|
Rest | 2 | 2017 | 915 | 0.120 |
Why?
|
Gyrus Cinguli | 3 | 2018 | 1115 | 0.120 |
Why?
|
Longevity | 2 | 2020 | 1062 | 0.110 |
Why?
|
Magnetic Resonance Imaging | 17 | 2018 | 36362 | 0.110 |
Why?
|
Analysis of Variance | 4 | 2016 | 6230 | 0.110 |
Why?
|
Limbic System | 1 | 2016 | 419 | 0.110 |
Why?
|
Adolescent | 13 | 2018 | 88196 | 0.110 |
Why?
|
Male | 28 | 2020 | 360035 | 0.110 |
Why?
|
Face | 3 | 2017 | 1020 | 0.110 |
Why?
|
Female | 30 | 2020 | 391875 | 0.110 |
Why?
|
Social Perception | 1 | 2016 | 433 | 0.100 |
Why?
|
Adult | 20 | 2020 | 220781 | 0.100 |
Why?
|
Aged, 80 and over | 7 | 2018 | 58859 | 0.100 |
Why?
|
Risk Factors | 5 | 2024 | 74055 | 0.100 |
Why?
|
Functional Laterality | 3 | 2013 | 2253 | 0.090 |
Why?
|
Middle Aged | 21 | 2018 | 220382 | 0.090 |
Why?
|
Cushing Syndrome | 1 | 2011 | 241 | 0.080 |
Why?
|
Receptors, Dopamine D2 | 1 | 2012 | 485 | 0.080 |
Why?
|
Photic Stimulation | 2 | 2012 | 1971 | 0.080 |
Why?
|
Diffusion Tensor Imaging | 1 | 2019 | 2399 | 0.080 |
Why?
|
Transcranial Magnetic Stimulation | 1 | 2018 | 1471 | 0.080 |
Why?
|
Personality | 1 | 2012 | 554 | 0.080 |
Why?
|
Walking | 1 | 2015 | 1199 | 0.080 |
Why?
|
Feasibility Studies | 1 | 2019 | 5236 | 0.070 |
Why?
|
Synaptic Transmission | 2 | 2012 | 1172 | 0.070 |
Why?
|
Longitudinal Studies | 2 | 2014 | 14565 | 0.070 |
Why?
|
Geriatric Assessment | 1 | 2015 | 1409 | 0.070 |
Why?
|
Lewy Body Disease | 1 | 2010 | 252 | 0.070 |
Why?
|
Acetylcholinesterase | 2 | 2005 | 156 | 0.070 |
Why?
|
Pattern Recognition, Visual | 1 | 2013 | 813 | 0.070 |
Why?
|
Adaptation, Psychological | 1 | 2017 | 2629 | 0.070 |
Why?
|
Frontal Lobe | 1 | 2013 | 1420 | 0.070 |
Why?
|
Regression Analysis | 4 | 2017 | 6340 | 0.060 |
Why?
|
Reward | 1 | 2012 | 970 | 0.060 |
Why?
|
Agnosia | 1 | 2005 | 66 | 0.060 |
Why?
|
Social Support | 1 | 2014 | 2167 | 0.060 |
Why?
|
Basal Nucleus of Meynert | 1 | 2004 | 24 | 0.060 |
Why?
|
Cost of Illness | 1 | 2014 | 1931 | 0.060 |
Why?
|
Cholinergic Fibers | 1 | 2004 | 69 | 0.060 |
Why?
|
Parkinson Disease | 2 | 2010 | 2875 | 0.060 |
Why?
|
Hippocampus | 1 | 2016 | 3755 | 0.050 |
Why?
|
Life Style | 1 | 2014 | 3909 | 0.050 |
Why?
|
Multiple Sclerosis | 1 | 2017 | 3220 | 0.050 |
Why?
|
Image Processing, Computer-Assisted | 6 | 2016 | 8967 | 0.050 |
Why?
|
Exercise | 1 | 2019 | 5874 | 0.050 |
Why?
|
Tomography, Emission-Computed | 1 | 2004 | 1122 | 0.050 |
Why?
|
Dihydroxyphenylalanine | 2 | 2010 | 74 | 0.040 |
Why?
|
Oxygen | 3 | 2016 | 4222 | 0.040 |
Why?
|
Psychiatric Status Rating Scales | 2 | 2020 | 6019 | 0.040 |
Why?
|
Comorbidity | 1 | 2012 | 10494 | 0.040 |
Why?
|
Drug Substitution | 1 | 2020 | 288 | 0.040 |
Why?
|
Austria | 1 | 2017 | 206 | 0.040 |
Why?
|
Family Relations | 1 | 2017 | 317 | 0.030 |
Why?
|
Mastication | 1 | 2014 | 53 | 0.030 |
Why?
|
Sex Factors | 2 | 2019 | 10538 | 0.030 |
Why?
|
Computers | 1 | 2017 | 596 | 0.030 |
Why?
|
Cross-Cultural Comparison | 1 | 2017 | 636 | 0.030 |
Why?
|
Treatment Failure | 1 | 2020 | 2642 | 0.030 |
Why?
|
Acetates | 2 | 2005 | 321 | 0.030 |
Why?
|
Individuality | 1 | 2015 | 300 | 0.030 |
Why?
|
Remission Induction | 1 | 2019 | 2394 | 0.030 |
Why?
|
Self Concept | 1 | 2017 | 1043 | 0.020 |
Why?
|
Temporal Lobe | 1 | 2018 | 1690 | 0.020 |
Why?
|
Malingering | 1 | 2011 | 75 | 0.020 |
Why?
|
Lewy Bodies | 1 | 2010 | 145 | 0.020 |
Why?
|
Adrenocorticotropic Hormone | 1 | 2011 | 616 | 0.020 |
Why?
|
Blood Glucose | 1 | 2004 | 6380 | 0.020 |
Why?
|
Fluorodeoxyglucose F18 | 2 | 2010 | 2008 | 0.020 |
Why?
|
Diagnostic and Statistical Manual of Mental Disorders | 1 | 2015 | 1988 | 0.020 |
Why?
|
Patient Selection | 1 | 2020 | 4240 | 0.020 |
Why?
|
Severity of Illness Index | 1 | 2005 | 15820 | 0.020 |
Why?
|
Acoustic Stimulation | 1 | 2011 | 1234 | 0.020 |
Why?
|
Follow-Up Studies | 2 | 2019 | 39078 | 0.020 |
Why?
|
Piperidines | 2 | 2005 | 1656 | 0.020 |
Why?
|
Haplotypes | 1 | 2012 | 2773 | 0.020 |
Why?
|
Pilot Projects | 1 | 2018 | 8611 | 0.020 |
Why?
|
Perception | 1 | 2011 | 1196 | 0.010 |
Why?
|
Binding, Competitive | 1 | 2005 | 1141 | 0.010 |
Why?
|
Carbon Radioisotopes | 1 | 2004 | 562 | 0.010 |
Why?
|
Positron-Emission Tomography | 2 | 2010 | 6475 | 0.010 |
Why?
|
Medical History Taking | 1 | 2005 | 773 | 0.010 |
Why?
|
Atrophy | 1 | 2005 | 1631 | 0.010 |
Why?
|
Circadian Rhythm | 1 | 2011 | 2572 | 0.010 |
Why?
|
Genotype | 1 | 2012 | 12976 | 0.010 |
Why?
|
Imaging, Three-Dimensional | 1 | 2010 | 4063 | 0.010 |
Why?
|
Chronic Disease | 1 | 2011 | 9309 | 0.010 |
Why?
|
Prognosis | 1 | 2017 | 29551 | 0.010 |
Why?
|
Time Factors | 1 | 2015 | 39947 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2012 | 15867 | 0.010 |
Why?
|
Prospective Studies | 1 | 2017 | 54339 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2017 | 64591 | 0.010 |
Why?
|
United States | 1 | 2017 | 72202 | 0.010 |
Why?
|